Dermatology

Latest News

Topical Roflumilast 0.3% Demonstrates Significant Efficacy Across Psoriasis Severity Measures in Updated Meta-Analysis / Image credit: ©molekuul.be/AdobeStock
Topical Roflumilast 0.3% Demonstrates Significant Efficacy Across Psoriasis Severity Measures in Updated Meta-Analysis

December 8th 2025

Topical roflumilast 0.3% improved IGA, PASI, itch, and symptom scores in plaque psoriasis with a safety profile comparable to vehicle.

T6 Degrader KT-621 Shows Biologic-Like Activity in Early Atopic Dermatitis Trial / image credit ©Designua/stock.adobe.com
Kymera's Oral STAT6 Degrader KT-621 Shows Biologic-Like Activity in Early Atopic Dermatitis Trial

December 8th 2025

Treating Body and Mind in Atopic Dermatitis: Priorities for Primary Care / image credit ©fizkes/stock.adobe.com
Treating Body and Mind in Atopic Dermatitis: Priorities for Primary Care

December 1st 2025

Atopic Dermatitis Management Beyond Skin Symptoms in Primary Care / image credit ©Monkey Business/stock.adobe.com
Atopic Dermatitis Management Beyond Skin Symptoms in Primary Care

November 27th 2025

Atopic Dermatitis Signs and Symptoms for Referral: Physical and Emotional Expertise/ image credit ©peopleimages.com/stock.adobe.com
Atopic Dermatitis Signs and Symptoms for Referral: Physical and Emotional Expertise

November 25th 2025

Latest CME Events & Activities

More News

© 2025 MJH Life Sciences

All rights reserved.